Why Attend
Join us at the international Phage Futures Congress 2022 as we create a stage upon which to initiate all-important discussions and forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.
Discover how you can be at the forefront of the developing phage therapy market and build your next phage product to target various animal health and agriculture markets. Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations and regulatory bodies.
Expect to hear & participate in:
- Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage-based application
- Regulatory discussions between international governing bodies with exclusive follow-up conversations with the experts
- Progressive talks on how CMOs can improve & participate in furthering the phage therapy market
- Insights into emerging markets for phage application, such as oncology, diagnostics & microbial gene therapy
TALK TO OUR SPEAKERS ABOUT...
1. How to design a successful phage clinical trial
2. How to manipulate the microbiome with phage therapy to treat chronic diseases
3. The implications and safety requirements of administering phage therapy to patients
4. What indications are suitable for phage therapy within Europe?
5. How to obtain broad phage host range and maintain synergy within a fixed cocktail
6. Applications of phage related products as an alternative strategy to access the market
7. How magistral preparative supports the personalised medicine method
8. The route to appropriate clinical data: through innovative trial design
9. How to alleviate future multi-drug resistance through phage evolution research
10. What are the commercial pathways for phage therapies?
2022 Advisory Board
Dr Gina Suh
Dr Todd Black
Jessica Sacher
Sandra Giannini
Who Will Be There
POSTER SESSION
Looking to showcase your recent work to the phage therapy community?
Our dedicated poster session is the perfect way to get your research noticed. Ideal for PhD students or Post-Doctoral researchers.
In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration). At the congress, your presentation will be displayed in a dedicated poster area.
By submitting, you are also eligible for €100 off the academic rate.
Apply to submit your poster here. The submission deadline is 13 May 2022.
2022 SPEAKERS
Dr Peter Beyer
Peter Beyer, a trained lawyer, is a Senior Advisor with the World Health Organization (WHO) in Geneva where he leads a team working on global initiatives on antimicrobial resistance. He focuses on developing global instruments to combat antimicrobial resistance and to foster the development of new antimicrobial treatments. Peter was instrumental in setting up the Global Antibiotic R&D Partnership (GARDP), a foundation that is developing new antibacterial treatments as well as the trilateral collaboration among the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO) and WHO. Previously, Peter Beyer was a Legal Advisor to the Swiss Federal Institute of Intellectual Property in Berne. He negotiated bilateral free trade agreements for the European Free Trade Association (EFTA) and was responsible for the bilateral dialogue between Switzerland and China on intellectual property. Prior to joining the Swiss civil service, Peter Beyer worked with the Ecologic Institute in Berlin on environmental law and policy.
Dr Gina Suh
Dr. Jean-Paul Pirnay
Tobi Nagel
Dr Danish Malik
Matthew Tebeau
Olivia McAuliffe
Dr. Edith Hessel
Dr Cara Fiore
Ruby Lin
Merav Bassan
Dr. Bassan was most recently Vice President Head of Translational Sciences at Teva Pharmaceutical Industries, Inc., where she was responsible for early stages of clinical development via translation from animal data to human. Prior to this role, Dr. Bassan served as Vice President of Project Leadership at Teva Pharmaceutical, where she managed project leaders overseeing end-to-end drug development at pre-clinical, PI-III and post marketing stages in multiple therapeutic areas, such as pain, oncology, women‘s health, endocrinology, GI, biosimilars and other areas. Overall, Dr. Bassan has over 20 years of leadership experience with clinical and drug development teams in her various roles at Teva Pharmaceutical and other smaller biotech companies. Dr. Bassan is also a member of the Israeli 8400 health network, a cross-sector network of leaders actualizing the global disruptive capabilities of Israel’s HealthTech ecosystem. Dr. Bassan holds a Ph.D. in Neuroscience from the Tel-Aviv University Sackler School of Medicine and completed a post-doctoral fellowship in Neuroscience at Harvard University.
Sofia Corte-Real
Christian Röhrig
Alexander Sulakvelidze
Dr. Alexander “Sandro” Sulakvelidze, Ph.D. is the President and CEO of Intralytix. He is an internationally recognized expert in phage technology who was instrumental in securing the first ever FDA-approval for phage-based food safety product in the World. Dr. Sulakvelidze has published extensively on the subject of phage therapy and biocontrol, including co-editing a major book about bacteriophages entitled “Bacteriophages: Biology and Applications”. He is the author of 15 issued and several pending patents in the field of bacteriophage technology.
Nancy Tawil
Nancy Tawil, Mcb.A, M. Eng, Ph.D., is the Chief Scientific Officer at Phagelux Inc. and a Professor of Biomedical Engineering at Polytechnique Montreal where she oversees scientific research, product development, and clinical strategy. Her research focuses on the development of novel heterofunctional materials and anti-infective treatments for multi-drug resistant infections. Her expertise and interests include drug delivery, phage science, polymer chemistry, and novel combination devices. Dr. Tawil has over 15 years in phage research experience and is named inventor on multiple patents that aim to bridge the gap between phage science and technology.
Felipe Molina PhD
My research is focused on bacterial genetics, the cell cycle of microorganisms and phages as biocontrol agents in dairy products.
Dr Minmin Yen
Dr. Yen is a 2018 MIT Technology Review Innovator Under 35 and a microbiologist with a global health and program management background. Since co-founding PhagePro, Dr. Yen has received numerous awards and won several startup competitions recognizing her innovative leadership in global health, such as the ASTMH Innovations Pitch Competition and LaunchBio's The Big Pitch. She has been selected for several fellowships, including the MassNextGen Fellowship for women-led early-stage life science businesses, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program. An advocate for DEI in both biotech and global health communities, Dr. Yen strives to center the voices and the needs of the most marginalized.
Paul Garofolo
Lorenz Leitner
Kristin Wannerberger
Kristin holds a Ph.D. in Biophysical Technology from Lund University, Sweden and a M.Sc. Chem. Eng. - Food and Dairy Technology. Kristin has more than 20 years of experience of Pharmaceutical Industry working with development of drugs covering various therapeutical areas and several administration forms. She has had various positions based in Sweden, Denmark and Switzerland and currently holds a position as Director Alliance Management R&D, based in Switzerland. She is directing several alliances in the field of the human microbiota/microbiome.
DOWNLOAD THE AGENDA
The Phage Futures Europe 2022 agenda is here! Here's what to expect:
- 200+ participants from academic, industry, biotech and regulatory bodies onsite
- European and global phage thought leaders on the speaking agenda and ready to answer your big questions
- 2 days of furthering phage therapy
"First conference really focused on moving phage therapy and phage-related technologies forward. A great combination of regulatory, commercial, and scientific presentations." – Shawna McCallin, Phage Forward
Download 2022 Europe Agenda
2022 Partners
GMP Partner
JAFRAL
Website: https://jafral.com/
JAFARAL is world’s leading CMO for production of bacteriophages, because it’s has more than 10 years’ experience in manufacturing of phages, other biologics production, large scale production and knowing GMP guidelines. Likewise, JAFRAL has all these years also been involved in plasmid DNA and recombinant proteins production at various levels. JAFRAL’s custom development and manufacturing services have helped developers across the globe to accelerate research and open up their laboratories for ground-breaking science and breakthrough discoveries.
Event Partners
Cellexus
Website: http://www.cellexus.com/
Cellexus was established in 2008, to develop a scalable single use bioreactor (SUB) for industrial and academic scientists to grow cell cultures in their laboratories, rapidly and in a controlled environment, for use in a wide range of applications including life sciences, brewing, biopharmaceutical and agricultural feed.
Vesale Bioscience
Website: https://phage.health/
At Vésale Bioscience, we fight multi-antibiotics resistant infections (AMR) with our personalized phage therapy solutions:
-We have developed the fast diagnostic tool Inteliphage®, an automated Phagogram®, that will recommend the optimal phages association (2 or 3) to fight the patient’s bacteria.
-We GMP produce a library of phages as API for tailored magistral preparations.
This approach dramatically increases the success rate of AMR treatments and we expect to have our first sales in 2022.
Innovation Partner
Biomes
BIOMES is a genomic deep-tech startup which seeks to improve the individual life by precision nutrition & health prevention. BIOMES is combining state-of-the-art high-throughput sequencing with machine learning algorithms to find significant patterns combining microbiota profiles and lifestyle & health phenotypes. With BIOMES first retail product, the INTEST.pro gut microbiome analysis, retails customers can discover their intestinal flora and life-changing effects by re-balancing their microbiome via personalized nutrition and analytic-based supplements. BIOMES provides high-throughput genomic lab services and deep data analysis solutions for industrial & academic partners leveraging a worldwide unique meta data-pool, containing of more than 31,000 biological microbiota profiles associated to individual health and lifestyle data.
TNO
Website: https://www.tno.nl/en/
TNO is a research and technology innovation institute which drives biomedical, technological and social innovations in collaboration with knowledge institutes, industrial partners and government authorities. Multidisciplinary teams of top scientists and technical experts enable us to model, mimic and measure health and disease risk. We connect experimental and clinical studies with innovative technologies to identify new biomarkers for health and disease, as well as substantiate the health benefit of compounds. Together, we can make a contribution to future health. Visit: https://www.tno.nl/en/ for more info
Lead Media Partner
Phage Directory
Website: https://phage.directory/
Phage Directory promotes and accelerates the safe and effective use of phages in medicine, agriculture, and biotechnology around the world. We provide insight and support to communities and organizations interested in understanding and using phages.
Phage Directory can support you to:
- Stay up-to-date on new developments in phage research and phage therapy
- Understand the regulatory, scientific and tech landscape around phages and phage therapy
- Find and recruit individuals with phage expertise
- Develop phage-based technologies and products
- Organize phage and phage therapy-related conferences, seminars and workshops
Media Partners
Bacteriophage.news
Website: https://www.bacteriophage.news/
Please visit our website for more information.Past attendees
TESTIMONIALS
Partner With Us
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact Ryan Sanderson, Commercial Partnerships Director at [email protected].
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact Laura Hobson, Senior Marketing Manager; [email protected]
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Registration ends in
Venue
Hotel Okura Amsterdam, Ferdinand Bolstraat 333, 1072 LH Amsterdam, Netherlands
We're excited to welcome you face-to-face in Amsterdam!
Click here to view local hotels.
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.